Northwire Canada EditionSunday, July 12, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Other

Cronos Group launches Lord Jones brand in Israel

By The Northwire Desk — AI Analysis Feb 02, 2026 · 20:19 CRON · 3.43 Cronos Group Inc
CRON · Price

Executive Summary

  • Cronos Group Inc. has officially launched its premium Lord Jones cannabis brand in Israel, marking a significant milestone in its "borderless product strategy."
  • The initial launch phase introduces five premium indoor-grown flower strains to the Israeli medical cannabis market, available in pharmacies across the country.
  • The move underscores Cronos's commitment to international growth by applying its global brand expertise and rigorous quality standards to meet local demand in a discerning medical market.

Key Details

  • Brand Launch: Introduction of the Lord Jones premium cannabis brand into the Israeli market.
  • Initial Product Offering: Five premium indoor-grown flower strains are available in the first phase.
  • Distribution Channels: Products are now available in pharmacies across Israel.
  • Production Methodology:
    • Cultivation: Small-batch indoor cultivation using carefully selected genetics.
    • Processing: Cold-cure process to preserve terpene richness, aroma, trichome density, and flower structure.
    • Quality Control: Hand-trimmed, produced in limited quantities, and extensively tested.
    • Packaging: Hand-packaged in glass jars to protect from light exposure and preserve terpene profiles.
  • Future Plans: Cronos plans to expand the Lord Jones brand in Israel with future special edition and limited-run products.
  • Strategic Context: The launch is described as part of a disciplined approach to international expansion, aiming to build globally relevant cannabis brands anchored in quality and innovation.

Notable Quotes

  • Mike Gorenstein, Chairman, President and CEO: "Israel has always represented a key market in our borderless product strategy... By introducing Lord Jones to Israeli patients, we are applying our global brand expertise to meet local demand while preserving the craftsmanship, quality standards and premium identity, which have come to define Lord Jones."
  • Adam Wagner, General Manager of Cronos Israel: "The launch of the Lord Jones brand in Israel marks an important milestone for us, bringing a premium standard to the Israeli medical market, which is grounded in expertise and intention... This end-to-end approach gives patients and pharmacists confidence in the standards behind the brand, delivering a premium defined by transparency and an unwavering commitment to quality."
Read the original news release →

More from Cronos Group Inc

Jun 16, 2026 · 16:15

Cronos Group Inc.

Other Jun 11, 2026 · 07:30

Spinach vapes claim Canadian crown, but execution risks and macro headwinds temper the upside.

Production / Operations May 11, 2026 · 07:30

Record profit and a fresh buyback cannot fully conceal a stalling European anchor acquisition.

Earnings May 06, 2026 · 17:25

Cronos Expands Spinach STIX Portfolio Amidst Consolidation and European Integration Risks

Other May 06, 2026 · 07:30

Cronos Expands Spinach Portfolio as Netherlands Acquisition Looms

Production / Operations Feb 26, 2026 · 07:35

Cronos Group Reports 2025 Fourth Quarter and Full-Year Results

Earnings